Visual Hallucinations and Impulse Control Disorder in Parkinson's Disease

Overview

Journal Int J Neuropsychopharmacol

Publisher Oxford University Press

Specialty Psychiatry

Date 2020 Jul 14

PMID 32658290

Citations 1

Authors

Nadia S Hejazi

Affiliations

Soon will be listed here.

Citing Articles

Low Dopamine D2 Receptor Expression Drives Gene Networks Related to GABA, cAMP, Growth and Neuroinflammation in Striatal Indirect Pathway Neurons.

Guerri L, Dobbs L, da Silva E Silva D, Meyers A, Ge A, Lecaj L Biol Psychiatry Glob Open Sci. 2023; 3(4):1104-1115.

PMID: 37881572 PMC: 10593893. DOI: 10.1016/j.bpsgos.2022.08.010.

References

Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M . Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Mov Disord. 2011; 26(3):464-8. DOI: 10.1002/mds.23501. View

Goldman J, Postuma R . Premotor and nonmotor features of Parkinson's disease. Curr Opin Neurol. 2014; 27(4):434-41. PMC: 4181670. DOI: 10.1097/WCO.0000000000000112. View

Alexander G . Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci. 2011; 6(3):259-80. PMC: 3181806. View

Goetz C . The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2012; 1(1):a008862. PMC: 3234454. DOI: 10.1101/cshperspect.a008862. View

Redensek S, Flisar D, Kojovic M, Gregoric Kramberger M, Georgiev D, Pirtosek Z . Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease. Front Pharmacol. 2019; 10:8. PMC: 6360186. DOI: 10.3389/fphar.2019.00008. View

Zainal Abidin S, Tan E, Chan S, Jaafar A, Lee A, Abd Hamid M . DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients. BMC Neurol. 2015; 15:59. PMC: 4417293. DOI: 10.1186/s12883-015-0316-2. View

Mindham R . Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry. 1970; 33(2):188-91. PMC: 493439. DOI: 10.1136/jnnp.33.2.188. View

Gruber D, Calmbach L, Kuhn A, Krause P, Kopp U, Schneider G . Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease. J Neural Transm (Vienna). 2019; 126(3):309-318. DOI: 10.1007/s00702-019-01972-7. View

Barnes J, David A . Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. 2001; 70(6):727-33. PMC: 1737396. DOI: 10.1136/jnnp.70.6.727. View

10.

Diederich N, Fenelon G, Stebbins G, Goetz C . Hallucinations in Parkinson disease. Nat Rev Neurol. 2009; 5(6):331-42. DOI: 10.1038/nrneurol.2009.62. View

11.

Lee J, Lee E, Park S, Lim J, Kim H, Kim J . Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord. 2009; 24(12):1803-10. DOI: 10.1002/mds.22678. View

12.

Twelves D, Perkins K, Counsell C . Systematic review of incidence studies of Parkinson's disease. Mov Disord. 2003; 18(1):19-31. DOI: 10.1002/mds.10305. View

13.

Dos Santos E, Duarte E, Miranda L, Asano A, Asano N, Maia M . Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease. J Clin Pharmacol. 2019; 59(7):1006-1013. DOI: 10.1002/jcph.1394. View

14.

Kraemmer J, Smith K, Weintraub D, Guillemot V, Nalls M, Cormier-Dequaire F . Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2016; 87(10):1106-11. PMC: 5098340. DOI: 10.1136/jnnp-2015-312848. View